Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank85
3Y CAGR+29.6%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+29.6%/yr
Annual compound
Percentile
P85
Within normal range
vs 3Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.39M | -62.7% |
| 2024 | $14.46M | +2.8% |
| 2023 | $14.06M | +467.1% |
| 2022 | $2.48M | +236.2% |
| 2021 | $-1.82M | +50.7% |
| 2020 | $-3.70M | -230.4% |
| 2019 | $-1.12M | +66.7% |
| 2018 | $-3.36M | -21.8% |
| 2017 | $-2.76M | -183.1% |
| 2016 | $-975000.00 | - |